H. Cohen

Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation.

Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation.